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Precis:  There is little disparity in breast cancer treatment communication and decision making 
experiences reported by Latinas with low acculturation vs other groups.  However, the approach 
taken by Latina patients with low acculturation with regard to treatment decision making 
represents an important challenge to health care providers.   
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Abstract 
Objectives: We examined race/ethnic differences in patient perspectives about their breast 
cancer treatment experiences. 
Methods:  A weighted random sample of women newly diagnosed with breast cancer in 2013-
15 in Los Angeles County and Georgia were sent surveys 2 months after surgery (N=5,080, 
70% response rate). The analytic sample was limited to patients in Los Angeles County 
(N=2,397). 
Results: The pattern of visits with different specialists before surgery was similar across 
race/ethnic groups. Low acculturated Latinas (Latinas-LA) were less likely to report high 
clinician communication quality for both surgeons and medical oncologists (under 69% vs over 
72% for all other groups, p<.05).  The proportion of patients who reported high satisfaction 
about how doctors worked together was similar across race/ethnic groups.  Latinas-LA were 
more likely to have a low autonomy decision style (48% vs 24%-50% for all other groups, 
p<.001) and were more likely to report getting too much information vs other ethnic groups (20% 
vs <16% for other groups, p<.001).   Patients who reported a low autonomy decision style were 
more likely to rate amount of information received for the surgery decision as “too much” (16% 
vs 9%, p<.001).  
Conclusions:  There is moderate disparity in breast cancer treatment communication and 
decision making experiences reported by Latinas with low acculturation vs other groups.  The 
approach to treatment decision making by Latinas with low acculturation represents an 
important challenge to health care providers.  Initiatives are needed to improve patient 
engagement in decision-making and increase clinician awareness of these challenges in this 
patient population.   
Key words: breast cancer, Latina health, treatment communication and decision making, 
women’s health, population-based observational studies, SEER epidemiology studies.   
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INTRODUCTION  
Efforts to improve cancer care delivery and outcomes have markedly changed the treatment 
experiences for patients.1-3 A key focus of these efforts has been reducing racial and ethnic 
disparities in the quality of treatment offered and improving the patient experience during and 
after treatment.4  Strategies that have been implemented include multidisciplinary approaches to 
treatment management, use of care navigators to support patient decision making and care 
coordination, and a greater focus on patient support into survivorship.   Taken together, these 
initiatives have the potential for reducing disparities in the treatment experience.   However, the 
main focus has been on reducing disparities between African American and whites.  Indeed, 
recent published research suggests disparities in initiation of treatment between these groups 
are small, perhaps reflecting the successes of these initiatives.5-11  Less is known about the 
treatment experiences of Latinas, a large and growing segment of the oncology patient 
population.     
Although Latinas represent about 15% of patients with breast cancer in the US,12 understanding 
Latina breast cancer treatment disparities is complicated by the fact that the US Latina 
population comprises individuals from many countries and diverse levels of acculturation.  
Furthermore, a large sample is required to disentangle cultural factors from SES factors 
because most low acculturated Latinas also have low levels of education.   
Latinas may be uniquely subject to disparate treatment due to language, cultural barriers or 
fears of discrimination.13   For example, language limitations may make it more difficult to 
communicate with their providers and cultural values may discourage assertiveness and 
engagement, even when language skills are adequate.   This may lead to differences in patient 
attitudes about treatment, the kind of treatment they get or their appraisal of the treatment 
experiences.  We examined race/ethnic differences in breast cancer patient’s perspectives 
about their treatment experiences, focusing on those of Latina patients of low and high 
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acculturation, including practice factors and physician factors, attitudes about decision making, 
and appraisal of communication with clinicians. 
METHODS 
Study Population and data collection 
The Individualized Cancer Care (iCanCare) Study is a population-based survey study of women 
with early-stage breast cancer and their providers. We identified and accrued a total of 7,810 
women aged 20-79 with newly diagnosed, early-stage breast cancer (stages I-II) as reported to 
the SEER registries of Georgia and Los Angeles County (LAC) in 2013-2015.  Women were 
accrued on a monthly basis and Latinas were oversampled using a novel and valid approach 
based on patient surnames which were available at time of accrual. 14   Patient surnames were 
compared to a list of names provided by the US Census Bureau of whom 50% or more 
indicated Hispanic ethnicity on the 2000 US census.  All patients with surnames on the list were 
selected into the iCanCare accrued sample.   Patients were ineligible if they had stage III or IV 
disease, Paget’s disease, tumors larger than 5cm, resided outside the registry areas, or could 
not complete a questionnaire in English or Spanish (N= 507).   Of the remaining 7,303 eligible 
women who were mailed surveys, 5,080 completed the survey, resulting in a 70% response 
(68%, 67%, 65%, 73% for Latinas, AA, Asians, and Whites, respectively).  We limited the 
analytic sample for this study to patients residing in Los Angeles County (LAC) because less 
than 3% of breast cancer cases in Georgia are Latina. Women with missing race data were also 
excluded from the analysis.   The details of the analytic sample of 2,397 women are displayed in 
Figure 1 Supplemental. 
Patients were identified shortly after diagnosis based on initial surgical pathology reports 
derived from a list of “definitive” surgical procedures, (performed with the intent of removing the 
entire tumor and obtaining clear margins). Surveys were mailed approximately 2 months after 
surgery, with median time from diagnosis to survey completion of 6.5 months (SD 3.2). Women 
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were asked about their treatment experiences, knowledge and attitudes, appraisal of clinician 
communication and their decision-making process.  To encourage response, we provided a $20 
cash incentive and used a modified Dillman approach to patient recruitment including reminders 
to non-respondents.15 All materials were sent in English and Spanish to those with Spanish 
surnames.14  A native Spanish speaking project manager in LAC engaged all patients in follow-
up which included the offer of a full phone interview if requested (and 19 completed) and re-
contact to complete missing data.  Responses to the survey were then merged with clinical data 
by the SEER registries and a de-identified analytic dataset was created. The study was 
approved by the University of Michigan Institutional Review Board and the state and institutional 
IRBs of the SEER registries.  
Measures 
The patient questionnaire content was guided by conceptual framework from a larger P01 
Program Project supporting this analysis (P01CA163233, The Challenges of Individualizing 
Treatment for Patients with Breast Cancer, PI: Katz SJ), our prior work,19 research questions 
and hypotheses. The items used in this analysis were taken from the P01 Program Project 
survey, where we included established measures when available and developed new 
measures, when necessary, drawing from the literature and our prior research.13,16-18  We used 
standard techniques to assess content validity, including review by survey design experts, 
cognitive pre-testing with 50 breast cancer patients, and pilot studies in selected clinic 
populations including several with low SES patient populations.  Nearly 100 instruments were 
reviewed and considered for inclusion in the patient survey.  Survey measures for the program 
project questionnaire were compiled in a comprehensive catalogue describing constructs, pilot 
results, scoring details, and whether the measure had been previously developed in both 
English and Spanish. Following questionnaire development, we posted any newly developed 
measures on our team website and NCI’s Grid-Enabled Measures Database for dissemination 
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to other researchers.  A Spanish version of the questionnaire was created using professional 
translation services and reviewed again by Spanish native speaking project staff.    
Practice and management factors: Patients were asked how they found out about the diagnosis 
of breast cancer (radiologist who did the biopsy, primary care doctor, surgeon or surgeon’s 
nurse, or other) and which types of specialists they consulted with before surgery, and what 
type of treatment they received (type of surgical management, radiation, chemotherapy).    
To assess perceived care coordination across clinicians, we asked respondents “During your 
breast cancer care, how satisfied were you with how your doctors worked together” (5 pts Likert 
scale from not at all to extremely satisfied).   
Informal decision support:  We asked patients to indicate how frequently family or friends 
engaged in treatment decision making by asking whether they: 1) attended doctor appointments 
where decisions about treatment plans were made, and 2) took notes for the respondent during 
the doctor’s appointment (each on 5-pt Likert scales from never to very often).   
Attitudes and beliefs about treatment decision-making: We first assessed patient decision style 
with a single item query “when it came to getting treatment for breast cancer, I wanted my 
doctor to tell me what do” (5 pt Likert scale from none to all of the time). Low autonomy decision 
style was defined as those who responded they wanted their doctor to tell them what to do “all 
of the time”.   We then assessed the degree to which patients felt that they deliberated, or 
“thought through” regarding their treatment, using a 4-item “decision deliberation” scale derived 
from measures of public deliberation adapted to apply to cancer treatment-related decisions.20 
Items assessed the extent to which a patient weighed the pros and cons of a decision, how 
much they thought through the issues important to the decision, how much they talked to others 
while they were making the decision, and how much they thought through and spent time 
thinking about the decision, and all had 5-pt Likert scale response options (from not at all to very 
much). An overall deliberation score was created using the mean of the responses to the four 
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items (range 1-5), with higher scores representing more deliberation (alpha .87). A score of 3 or 
less indicated a less deliberative decision process. We used 3 items to assess patient’s 
perceptions about the adequacy of the amount of information they received about specific 
treatments using 1 item each for surgery, radiation, and systemic chemotherapy21 (response 
categories were not enough, just right, too much, or not applicable if doctor did not offer the 
treatment).     
 
Patient assessment of clinician communication quality: This was examined using a modified 
version of the Health Care Climate Questionnaire Scale,22  a scale specifically developed to 
assess patient perceptions of communication with clinicians. The scale assessed 4 domains by 
asking patients to report how often they thought their breast cancer clinicians (surgeon or 
oncologist assessed separately): 1) “Understood how I saw things with respect to my breast 
cancer”, 2) “Listened to how I would like to handle my breast cancer treatment”, and 3) 
“Encouraged me to ask questions” (5 pt Likert scale from not at all true to very true).23   
Responses were summed and a cutoff of 4.0 or greater (quite true or very true) was used to 
indicate high vs. low physician communication quality.   
Sociodemographic and other covariates: Race/ethnicity categories were derived from patient 
report (White, Black, Latina, Asian, other).  Latinas were further divided into low and higher 
acculturation (Latinas-LA, Latinas-HA) based on the Short Acculturation Scale for Hispanics 
(SASH) which has been widely used to assess acculturation in Hispanics, and previously been 
validated by our team in the Latina breast cancer population.  The SASH includes 5 items 
related to use of Spanish language in different contexts (read, speak, think).  Following 
methodologies developed and published in prior work, we summed and dichotomized the 
measure into low versus higher score groups using a median split.14  Low scores on the binary 
measure was indication of low acculturation (Latina-LA).   We also assessed age, education 
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level, and health literacy using the single item validated measure.24   Additional patient reported 
variables included country of origin, well-being at the time of survey completion (general self-
reported health status from poor to excellent), and medical comorbidities (0, 1, 2 or more) 
derived from a list pertinent to cancer patients. We also included number of months between 
diagnosis and survey completion.25   
Analysis 
We first described the distribution of population characteristics, practice and management 
factors, attitudes and beliefs about treatment decision-making, informal decision support and 
perceived care coordination by race/ethnicity.  We then examined the proportion of patients who 
reported low autonomy decision style, low treatment deliberation, and low appraisal of the 
amount of information they received regarding the surgery decision by race/ethnicity. These are 
presented as marginal probabilities based on multivariable logistic models which adjust for age, 
education, health status, comorbidities, health literacy, country of origin, months between 
diagnosis and survey completion, and treatments received. All models incorporated survey and 
non-response weights so that statistical inference is representative of the target population. 
Finally, we evaluated the relationship between patient reports of the adequacy of the amount of 
information received about the surgery decision and treatment decision style controlling for 
other factors.    
RESULTS 
Table 1 shows that the population was diverse with regard to education (one third high school or 
less), age (one quarter age 50 or less), and health literacy (one half with low health literacy).   
Latinas-LA were much more likely than other groups to be lower educated, younger age, have 
low health literacy, and poorer health status. Two thirds (66%) reported they were born in 
Mexico, 21% in Central America, 8% in other Latin American Countries, and 4% in the United 
States.   The average number of years in the US among first generation Latinas was 30 (SD 
Page 9 of 27 Cancer
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
9 
 
12).   The Asian patient population was very diverse (43% Filipino, 26% Chinese, 11% Korean, 
11% Japanese, 4% Vietnamese, 1% Asian Indian).   Forty-two percent of patients found out 
about their diagnosis from a radiologist, 25% from their primary care doctor, and 33% from their 
surgeon or surgeon’s office, with no significant differences in source of diagnosis between 
Latinas-LA and other race/ethnic groups.   Rates of breast conserving surgery option varied 
from 50% among Asians to 71% among White-non Latinas (p<.001) reflecting the complexity of 
surgical treatment decision-making.9,26   
Table 2 shows the distribution of practice and decision appraisal factors by race/ethnicity. 
Patient report of visits with different specialists prior to surgery were very similar across 
race/ethnic groups.  Although, there was similarly high appraisal regarding how doctors worked 
together during the breast cancer care across race/ethnic groups, when compared to other 
race/ethnic subgroups, Latinas-LA were less likely to report high clinician communication quality 
for both surgeons and medical oncologists (under 69% vs over 72% for all other groups, p<.05). 
Importantly, patients reported very high frequency of engagement of informal decision support.  
Nearly three quarters reported that a decision supporter often/very often attended visits and half 
reported that support person took notes often/very often.   Latinas-LA had particularly high 
engagement of a decision support person: for example, 61% of Latinas-LA had a note taker 
often/very often compared to 48%-57% for other ethnic groups (p=.007).  
Figure 1a and 1b show the marginal percentages of patients who reported low autonomy 
decision style and low treatment deliberation by race/ethnicity, from a multivariable logistic 
regression which controls for age, education, health status, comorbidities, health literacy, 
country of origin, months between diagnosis and survey completion, and treatments received. 
The rates of both low autonomy decision styles and low treatment deliberation varied 
significantly by race (p<.001, p=.008). Overall, 34% reported a low autonomy decision style. 
Latinas-LA were more likely to have a low autonomy decision style (48% vs 24%, 36%, 50% 
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and 33% for whites, AA, Asians, and Latinas-HA, p<.001).   About one third (35%) reported low 
deliberation (45% vs 32%, 29%, 38% and 37% for whites, AA, Asians, and Latinas-HA, p=.006) 
Figure 2 shows marginal distribution of patient appraisal of amount of information received 
regarding the surgery decision by race and ethnicity, from a multivariable logistic regression 
adjusting for the factors above.   Latinas-LA were more likely to report getting too much 
information (vs just right or too little) than other racial/ethnic groups (20% vs 7%, 10%, 16% and 
12% for whites, AA, Asians, and Latinas-HA, respectively p<.001).  Patients who reported a low 
autonomy decision style were more likely to rate amount of information received for the surgery 
decision as too much (16% vs 8%, p<.001).  
DISCUSSION 
Our findings in this large, diverse and contemporary sample of patients recently diagnosed with 
breast cancer reinforce the special challenges Latinas with low acculturation (Latinas-LA) face 
when engaging health care providers after a diagnosis of cancer.  Latinas-LA had much lower 
levels of education and health literacy.  Combined with low English fluency, these factors 
represent formidable barriers to high quality communication and treatment decision making after 
diagnosis of breast cancer.  Yet, we observed a remarkable lack of disparity in a number of 
important communication and treatment factors.   We observed no substantial race/ethnic 
gradients in multi-disciplinary provider decision management or patient report of how well 
doctors worked together.  Furthermore, Latinas reported similarly high rates of engagement of 
informal decision support from family members or friends, such as attending a doctor’s 
appointment or taking notes during the appointment.  Finally, rates of different treatments were 
similar across the race/ethnic groups.   Taken together, this is strong evidence of the high 
quality of treatment communication and decision-making reported by Latinas-LA, as well as by 
patients from other race/ethnic groups.     
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However, we did observe some key significant differences in patient care and patient 
experiences reported by Latinas compared with other patient groups.  First, Latinas appear to 
approach treatment decision making differently than other cultural groups; we found that Latinas 
were more likely to report low autonomy decision styles—thus more likely to defer to clinicians—
and to reported limited deliberation about treatment types. Interestingly, Latinas-LA were also 
much more likely to report that they had too much information related to tests and treatments vs. 
too little or just the right amount of information. This raises the possibility that a deferential 
decision style may lead to feeling overwhelmed by the complexity of treatment decision making 
for cancer.    Indeed, the fact that Latinas-LA reported lower appraisal of surgeon and medical 
oncologists quality of communication suggests they do not feel their providers are responding 
completely to their individual needs. This suggest potential lack of cultural competency 
approaches to communication on the part of clinicians,27 but could also be exacerbated by lack 
of specific interpreter services in some settings. We also note that Asians reported similar 
experiences with regard to low autonomy decision style and potential information overload. This 
reinforces that other ethnic groups may be vulnerable because of cultural or language barriers.   
The prior literature focused on Latina experience after diagnosis of breast cancer is surprisingly 
sparse and variably executed.  Few studies have been population-based13,19,28,29 and these 
studies are dated.  Other studies have been limited by low response rates, small samples, or 
inadequate granular measures of communication and decision making.30-33  Furthermore, these 
studies have tended to overreach with regard to conclusions about the presence of disparities 
based on very small differences between SES subgroups in limited number of clinical settings.   
Yet overall, the results of this current study identifying areas for improving the engagement of 
Latina patients in treatment decision making and patient-clinician communication are consistent 
with prior work that calls for more culturally tailored and patient centered communication around 
cancer treatment.19,27,34 
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Aspects of the study merit comment. We oversampled Latinas using an innovative approach 
previously validated by our team.14 and achieved a very high response rate nearly comparable 
among Latinas compared with other subgroups.  We used established granular measures to 
assess patient’s perspectives about the treatment context and communication and decision 
making.  We used sample weights to account for the sampling design and multiple imputation 
and sample weighting to address missing values and differential non-response.  However, there 
are some limitations.   Results are generalizable to one large metropolitan area of the United 
States containing over 10 million people.  As reflected in our results, Latinas in Los Angeles 
County are predominantly from Mexico and Central America.  Thus, results cannot be 
necessarily extended to Latinas from other areas of the world.   We cannot exclude the 
possibility of response bias due to different interpretations of questions across cultural groups.   
We may have under-represented patients with very low literacy levels because the dominant 
mode of inquiry was a written survey.  We did not query patients about translation services or 
language fluency of the providers, though these factors are well-known barriers to care.35-37   
Finally, our results regarding Asian patients are limited because of the highly diverse array of 
ethnic minorities within this group (over a dozen different Asian populations in LA county) and 
translation of the questionnaire for each group was beyond the scope of the study.  
Furthermore, our measure of low acculturation, the Short Acculturation Scale for Hispanics, has 
not been adopted or validated in other ethnic groups.  
Implications for patient care 
Taken together, our results suggest some positive news with regard to the lack of disparities in 
some key aspects of breast cancer treatment, including source of diagnosis, perceived 
coordination of services, and type of treatment. Despite these similar patterns, our results 
highlight clinicians may face challenges to engaging the Latina-Low acculturation population in 
optimal treatment decision making processes.  Breast cancer decision making is increasingly 
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complex and many patients feel the burden of decision making after diagnosis.  Providers are 
increasingly encouraged to achieve patient centered communication and shared decision 
making with their patients, yet this may be particularly difficult if patients are reluctant to 
participate.   Latinas with low acculturation may be particularly vulnerable, given they desire less 
engagement in decision making and are more often overwhelmed with the amount of 
information. Other groups, including Asian Americans with low acculturation and language 
barriers, may also be vulnerable to lower quality decision making processes. For these types of 
patients, cancer clinicians have a special responsibility to support them in navigation of decision 
making and deliberation about treatment choices.  Strategies to increase engagement and 
address these issues in this patient population could include communication skills and cultural 
competence training for clinicians.27  The fact that many patients receive news of their diagnosis 
from non-oncology providers, underscores the need for this training even in providers not 
directly connected to the cancer care.     
 
Another key opportunity is to better involve informal decision support people in the decision 
making process.  Indeed, most patients (including Latinas with low acculturation) reported 
having someone in the exam room and Latinas were most likely to have someone taking notes.  
This may provide an opportunity for clinicians to engage support people to ensure that patients 
are comfortable with the information provided and proactive to address deficits. Taken together, 
these initiatives could ensure that shared decision making is optimally achieved for this 
important and growing population of patients with cancer who may face cultural or linguistic 
barriers.    
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FIGURE LEGENDS 
Figure 1: 1a) Percentage of patients who reported a low autonomy decision style by 
race/ethnicity; 1b) Percentage of patients who reported low treatment decision deliberation by 
race/ethnicity. Presented rates are marginal probabilities derived from a multivariable logistic 
model controlling for age, education, health literacy, health status, and comorbidities.  Vertical 
bars are 95% confidence intervals.   
Figure 2:  Patient report of the amount of information they received regarding surgery treatment 
decisions by race/ethnicity. Presented rates are marginal probabilities derived from a 
multivariable logistic model controlling for age, education, health literacy, treatments, health 
status, and comorbidities. Weighted to reflect sampling and response rates.  
Figure 1 Supplemental:  Patient flow into the study. This figure depicts the flow of patients into 
the study from those initially identified to the final analytic sample. 
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Table 1: Patient Characteristics by Race/Ethnic Groups 533 
 White 
(n=750) 
Black 
(n=327) 
Asian 
(n=418) 
Latina, 
Higher 
Acculturation 
(n=421) 
Latina, Low 
Acculturation 
(n=473) 
Total 
Education       
High School or Less 117 (16%) 71 (22%) 62 (15%) 178 (43%) 366 (79%) 794 (34%) 
Some College or Technical 
School 
275 (37%) 146 (46%) 71 (17%) 145 (35%) 72 (16%) 709 (30%) 
College Graduate or More 350 (47%) 101 (32%) 280 (68%) 91 (22%) 25 (5%) 847 (36%) 
       
Age       
50 or Less 91 (12%) 36 (11%) 123 (29%) 145 (34%) 163 (34%) 558 (23%) 
51 - 65 360 (48%) 159 (49%) 199 (48%) 178 (42%) 195 (41%) 1091 (45%) 
Over 65 298 (40%) 132 (40%) 96 (23%) 105 (25%) 117 (25%) 748 (31%) 
       
Comorbidities       
0 552 (75%) 181 (57%) 286 (70%) 298 (71%) 302 (65%) 1619 (69%) 
1 144 (19%) 101 (32%) 106 (26%) 92 (22%) 144 (31%) 587 (25%) 
2 + 45 (6%) 37 (11%) 17 (4%) 28 (7%) 21 (4%) 148 (6%) 
       
Health Literacy       
High Health Literacy 507 (68%) 192 (60%) 185 (44%) 206 (49%) 93 (20%) 1183 (50%) 
Low Health Literacy 234 (32%) 127 (40%) 232 (56%) 216 (51%) 381 (80%) 1190 (50%) 
       
Health Status       
Poor, Fair 98 (13%) 78 (24%) 66 (16%) 88 (21%) 156 (33%) 485 (20%) 
Good 245 (33%) 134 (41%) 170 (41%) 182 (44%) 208 (44%) 939 (40%) 
Very Good, Excellent 399 (54%) 113 (35%) 179 (43%) 151 (36%) 106 (23%) 948 (40%) 
       
Treatment       
BCS 530 (71%) 230 (71%) 207 (50%) 261 (63%) 287 (62%) 1515 (65%) 
Unilaterial Mastectomy 111 (15%) 65 (20%) 140 (34%) 91 (22%) 129 (28%) 536 (23%) 
Bilateral Mastectomy 100 (14%) 26 (8%) 65 (16%) 64 (16%) 43 (9%) 298 (13%) 
All numbers are column % by category and are unweighted. All differences are significant (chi-square 534 
p<.001) 535 
 536 
 537 
 538 
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Table 2: Distribution of Practice and Decision Factors by Race/Ethnicity 542 
  
White Black Asian 
Latina, Low 
Acculturation 
Latina, 
Higher 
Acculturation 
Overall 
              
Providers Consulted before Surgery 
Radiation Oncologist (p=.005) 45% 47% 35% 41% 45% 43% 
Medical Oncologist (p=.002) 47% 45% 48% 51% 58% 50% 
Plastic Surgeon (p=.002 26% 29% 30% 38% 26% 29% 
Primary Care Provider (p=.263) 53% 58% 55% 50% 52% 53% 
              
High Clinician Communication Quality 
Surgeon (p=.001) 79% 76% 75% 77% 69% 76% 
Medical Oncologist (p=.026) 74% 72% 76% 76% 67% 73% 
              
High Satisfaction with How Doctors Worked Together  (p=.001) 
  79% 81% 77% 77% 81% 79% 
              
Participation of family and friends in treatment decisions 
Attended Doctor Appointments (p= .044) 68% 69% 73% 80% 77% 73% 
Took Notes during Appointment (p=.007) 48% 57% 53% 54% 61% 54% 
 543 
 544 
 545 
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Figure 1a: Percentage of patients who reported a low autonomy decision style by race/ethnicity. Presented 
rates are marginal probabilities derived from a multivariable logistic model controlling for age, education, 
health literacy, health status, and comorbidities.  Vertical bars are 95% confidence intervals.    
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Figure 1b: Percentage of patients who reported low treatment decision deliberation by race/ethnicity. 
Presented rates are marginal probabilities derived from a multivariable logistic model controlling for age, 
education, health literacy, health status, and comorbidities.  Vertical bars are 95% confidence intervals.  
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Figure 2: Patient report of the amount of information they received regarding surgery treatment decisions 
by race/ethnicity. Presented rates are marginal probabilities derived from a multivariable logistic model 
controlling for age, education, health literacy, treatments, health status, and comorbidities. Weighted to 
reflect sampling and response rates.  
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